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Abstract
Transforming growth factor-b (TGF-b) is an important regulator of many cellular and immunological functions. 
It is often deposited in extracellular matrices in a latent form. This commentary is to draw attention to the like-
lihood that preparing cell-free matrices from tissue cultures by high pH buffers, such as ammonium hydroxide, 
can activate the TGF-b. Therefore, cells subsequently seeded onto such matrices may respond to the presence 
of active TGF-b in addition to interactions with macromolecular extracellular matrix components. (Folia Histo-
chemica et Cytobiologica 2019, Vol. 57, No. 4, 157–158)
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As far back as the 1980s the roles of extracellular ma-
trix (ECM) components in regulating cell behaviour 
became increasingly popular. In addition to reduc-
tionist work in isolating and carefully characterising 
individual matrix macromolecules, efforts were made 
to assess whole matrices. Gospodarowicz’s group 
identified several methods to grow cell monolayers 
to confluency, allowing them to assemble extracel-
lular matrices, then removing the cells to leave the 
matrix for analysis, or to seed other cells on them 
[1–3]. Among these techniques, low concentrations 
of detergent, such as Triton X-100 together with hy-
potonic solutions containing ammonium hydroxide 
were developed. This high pH method is effective, 
and little cell debris remains attached to the matrices 
that are left largely intact. 
At that time, little was known about transforming 
growth factor-b (TGF-b), but in the succeeding few 
years it became apparent that this important growth 
factor is expressed in a latent form. Activation of 
TGF-b could be achieved in various ways, and early ex-
periments with soluble, medium-derived growth factor 
showed that extremes of pH were highly effective 
[4–6]. Subsequently, a number of more physiologically 
relevant mechanisms to activate TGF-b have been 
characterised, including proteases, thrombospon-
din-1, reactive oxygen species and several integrin 
receptors [5, 7–10]. 
Further developments in the field showed that 
latent TGF-b could be inserted into the extracellu-
lar matrix through its interaction with large latent 
TGF-binding proteins (LTBPs), of which four distinct 
types are now known in mammals [11]. In this way the 
ECM serves as a reservoir of latent TGF-b by virtue 
of its association with a structural matrix component, 
i.e. LTBP [12, 13]. 
What appears to have escaped widespread atten-
tion is that preparation of cell-free matrices from cell 
cultures through the use of ammonium hydroxide 
can activate matrix-associated TGF-b. Therefore, 
cells subsequently seeded onto matrices prepared in 
this way will encounter not only matrix components, 
interacting with integrins, syndecans, CD44 etc., but 
also activated TGF-b. Many years ago we found that 
matrices prepared from PF-HR9 mouse endodermal 
cells by alkali treatment would inhibit subsequently 
seeded mink lung epithelial cells (Mv1Lu) (M. Austria 
& J. Couchman, unpublished results). It is well known 
that TGF-b inhibits the proliferation of these cells 
[14], and in our case the inhibition could be overcome 
by TGF-b-specific blocking antibodies. 
Even today current methods describe the use of 
20 mM ammonium hydroxide (sometimes in PBS with 
158 John R. Couchman
©Polish Society for Histochemistry and Cytochemistry
Folia Histochem Cytobiol. 2019
10.5603/FHC.a2019.0017
www.fhc.viamedica.pl
detergent [15, 16], or more usually in hypotonic con-
ditions without detergent [17]), to prepare cell-free 
matrices, but there is no mention of the possibility that 
latent TGF-b can be activated by this method. I have 
often encountered young scientists who use this meth-
od and many are surprised when I advise them that it 
can result in the activation of the matrix-associated 
TGF-b. Therefore, the purpose of this commentary 
is to bring this aspect of matrix biology to scientists’ 
attention. Where this is a key issue, other methods at 
neutral pH can be used, such as 2 M urea together with 
non-ionic detergents and hypotonic buffers [3, 17].
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